Smooth muscle migration in atherosclerosis and restenosis

Journal of Clinical Investigation

Volumn 100, Issue 11 SUPPL., 1997, Pages

  Schwartz, Stephen M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ANIMAL MODEL; ATHEROGENESIS; ATHEROSCLEROSIS; CELL MIGRATION; INTIMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; REVIEW; VASCULAR SMOOTH MUSCLE; WOUND HEALING;

ANIMALS; ARTERIOSCLEROSIS; CELL ADHESION MOLECULES; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; HUMANS; MICE; MUSCLE, SMOOTH, VASCULAR; TUNICA INTIMA; VASCULAR DISEASES; WOUND HEALING;

EID: 0031456015     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Schwanz, S.M., D. deBlois, and E.R.M. O'Brien. 1995. The intima: soil for atherosclerosis and restenosis. Circ. Res. 77:445-465.
2. Majesky, M.W., and S.M. Schwartz. 1997. An origin tor smooth muscle cells from endothelium? Circ. Res. 80:601-603.
3. Lowery, M.C., J.C. Carey, M. Keating, and A.R. Brothman. 1995. Strong correlation of elastin deletions, detected by FISH, with Williams syndrome: evaluation of 235 patients. Am. J. Hum. Genet. 57:49-53.
4. Bostrom, H., K. Willetts, M. Pekny, P. Leveen, P. Lindahl, H. Hedstrand, M. Pekna, M. Hellstrom, S. Gebre Medhin, M. Schalling, et al. 1996. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell. 85:863-873.
5. Murry, C.E., C.T. Gipaya, T. Bartosek, E.P. Benditt, and S.M. Schwartz. 1997. Monoclonality of smooth muscle cells in human atherosclerosis. Am. J. Pathol. In press.
6. deRuiter, M.C., R.E. Poelmann, J.C. VanMunsteren, V. Mironov, R.R. Markwald, and A.C. Gittenberger-de Groot. 1997. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in viva and in vitro. Circ. Res. 80:444-451.
7. Li, J., L. Sensebé, P. Hervé, and P. Charbord. 1995. Nontransformed colony-derived stromal cell lines from normal human marrows. II. Phenotypic characterization and differentiation pathway. Exp. Hematol. 23:133-141.
8. Bennett, M.R., V. Lindner, D. deBlois, M.A. Reidy, and S.M. Schwartz. 1997. The effect of antisense C-MYC oligonucleotides on the rat carotid artery: dissecting the mechanism of action. Arterioscler. Thromb. In press.
9. Thayer, J.M., C.M. Giachelli, P.E. Mirkes, and S.M. Schwartz. 1995. Expression of osteopontin in the head process late in gastrulation in the rat. J. Exp. Zool. 272:240-244.
10. Liaw, L., D.M. Lombardi, M.M. Almeida, S.M. Schwartz, D. deBlois, and C.M. Giachelli. 1997. Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening following endothelial denudation. Arterioscler. Thromb. Vasc. biol. 17:188-193.
11. Hoshiga, M., C.E. Alpers, L.L. Smith, C.M. Giachelli, and S.M. Schwartz. 1995. avb3 integrin expression in normal and atherosclerotic artery. Circ. Res. 77:1129-1135.
12. Matsuno, H., J.M. Stassen, J. Vermylen, and H. Deckmyn. 1994. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation. 90:2203-2206.
13. 3 integrin with a small peptide antagonist GpenGRGDSPCA. J. Vasc. Surg. 19:125-134.
14. Gotwals, P.J., G. Chi Rosso, V. Lindner, J. Yang, L. Ling, S.E. Fawell, and V.E. Koteliansky. 1996. The α1β1 integrin is expressed during neointima formation in rat arteries and mediates collagen matrix reorganization. J. Clin. Invest. 97:2469-2477.
15. Clyman, R.I., B.W. Goetzman, Y.Q. Chen, F. Mauray, R.H. Kramer, R. Pytela, and L.M. Schnapp. 1996. Changes in endothelial cell and smooth muscle cell integrin expression during closure of the ductus arteriosus: an immunohistochemical comparison of the fetal, preterm newborn, and full-term newborn rhesus monkey ductus. Pediatr. Res. 40:198-208.
16. Svee, K., J. White, P. Vaillant, J. Jessurun, U. Roongta, M. Krumwiede, D. Johnson, and C. Henke. 1996. Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44. J. Clin. Invest. 98:1713-1727.
17. Weber, G.F., S. Ashkar, M.J. Glimcher, and H. Cantor. 1996. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science (Wash. DC). 271:509-512.
18. Jain, M., Q. He, W.S. Lee, S. Kashiki, L.C. Foster, J.C. Tsai, M.E. Lee, and E. Haber. 1996. Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. J. Clin. Invest. 97:596-603.
19. Bendeck, M.P., C. Irvin, and M.A. Reidy. 1996. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ. Res. 78:38-43.
20. Clarkson, T.B., R.W. Prichard, T.M. Morgan, G.S. Petrick, and K.P. Klein. 1994. Remodeling of coronary arteries in human and nonhuman primates. J. Am. Med. Assoc. 271:289-294.
21. Mintz, G.S., J.A. Kovach, S.P. Javier, C.J. Ditrano, and M.B. Leon. 1993. Geometric remodeling is the predominant mechanism of late lumen loss after coronary angioplasty (abstract). Circulation. 88 (No. 4, Pt. 2):I-654.
22. Mogford, J.E., G.E. Davis, S.H. Platts, and G.A. Meininger. 1996. Vascular smooth muscle alpha(v)beta(3) integrin mediates arteriolar vasodilation in response to RGD peptides. Circ. Res. 79:821-826.